Summary
For many people, bumping into a chair or getting a paper cut means momentary pain, followed by quick healing. But for those with hemophilia, a disease that renders its sufferers unable to clot blood effectively and control hemorrhaging after minor injuries, the healing time can be much more arduous. Resulting from mutations in genes that code for blood proteins necessary for clotting, hemophilia is an ancient, hereditary disease that usually affects males and can be classified as severe, moderate, or mild. Hemophilia, a detailed and easy-to-read guide filled with informative stories of the disease’s history, strives to educate readers about the science of hemophilia, while emphasizing how people with this disease can live full and productive lives. The development and technology behind the evolution of treatments for hemophilia are also discussed.
Specifications
Full-color photographs and illustrations. Sidebars. Further reading. Web sites. References. Glossary. Index.
About the Author(s)
Michelle Raabe, Ph.D., holds a degree in molecular virology and microbiology from the University of Pittsburgh School of Medicine. The medical research projects Dr. Raabe has worked on range from babies infected with HIV to vaccine development for horses. As a teacher, she has taught college classes in microbiology, human biology, and anatomy and physiology. Dr. Raabe has published in a number of science journals and has worked as a developmental science writer and editor.